Granahan Investment Management - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 48 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$1,349,000
-54.1%
217,295
-45.0%
0.03%
-56.1%
Q4 2020$2,941,000
+12.5%
394,810
-8.5%
0.07%
-25.8%
Q3 2020$2,615,000
+27.6%
431,470
+75.8%
0.09%
+20.3%
Q2 2020$2,049,000
+27.7%
245,377
-9.2%
0.07%
-14.0%
Q1 2020$1,605,000
-35.9%
270,209
-30.0%
0.09%
-25.2%
Q4 2019$2,504,000
+14.2%
385,880
-15.4%
0.12%
-5.0%
Q3 2019$2,193,000
+24.9%
455,979
+3.8%
0.12%
+39.1%
Q2 2019$1,756,000
-11.9%
439,083
+6.9%
0.09%
-18.7%
Q1 2019$1,993,000
-14.4%
410,932
+12.6%
0.11%
-35.2%
Q4 2018$2,328,000
+27.2%
364,933
+63.6%
0.16%
+66.7%
Q3 2018$1,830,000
+207.6%
223,123
+291.4%
0.10%
+175.0%
Q2 2018$595,000
+3.8%
57,002
+20.3%
0.04%
-12.2%
Q1 2018$573,000
-3.2%
47,376
-19.8%
0.04%
-12.8%
Q4 2017$592,000
+7.6%
59,044
+19.1%
0.05%
+2.2%
Q3 2017$550,00049,5930.05%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 900,000$5,742,0002.14%
Southpoint Capital Advisors LP 3,997,214$25,502,0001.23%
Avoro Capital Advisors LLC 1,105,999$7,056,0000.42%
683 Capital Management, LLC 971,351$6,197,0000.38%
Eventide Asset Management 720,000$4,594,0000.20%
Granahan Investment Management 364,933$2,328,0000.16%
Zebra Capital Management LLC 17,568$112,0000.07%
Hartford Financial Management Inc. 10,000$64,0000.02%
Weiss Multi-Strategy Advisers LLC 25,000$160,0000.01%
MEEDER ASSET MANAGEMENT INC 9,740$62,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders